Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2023 | YoY |
|---|---|---|
| Revenue | 130.63M | 8.83% |
| Gross profit | 37.6M | 4.22% |
| Net profit | 6.72M | 25.47% |
| EBITDA | 21.6M | 5.32% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €151.04M |
Number of shares | 81.32M |
52-week high/low | €1.89 - €1.33 |
| Dividends | No |
Beta | 0.47 |
P/E ratio | 21.29 |
PEG ratio | 0.21 |
P/B ratio | 2.78 |
P/S ratio | 1.13 |
Company profile
Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services pharmaceutical, consumer, healthcare, cosmetics, and food and beverage companies. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.
| Name | PROBIOTEC LTD |
| CEO | Wesley Stringer CPA, LLB |
| Headquarters | Laverton North,
vic Australia |
| Website | |
| IPO | 11/13/2006 |
| Employees | 111 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Australian Securities Exchange Ltd | PBP.AX |